Indoco Remedies Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 18.44 Cr
- Company Age 77 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 440.06 Cr
- Satisfied Charges ₹ 667.82 Cr
- Revenue Growth 8.23%
- Profit Growth -8.52%
- Ebitda -12.88%
- Net Worth 13.57%
- Total Assets 11.57%
About Indoco Remedies
Indoco Remedies Limited (IRL) was founded in India on 23 August 1947 and has a glorious history of 77 years and five months. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532612 and on the National Stock Exchange(NSE) under INDOCO.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 18.44 Cr.
The company currently has active open charges totaling ₹440.06 Cr. The company has closed loans amounting to ₹667.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Indoco Remedies Limited India are Pramod Ghorpade as CFO and Hariharan Ramanathan as Company Secretary. Sundeep Bambolkar, Aditi Panandikar, Suresh Kare, and Five other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Indoco Remedies Limited offer?
Indoco Remedies Limited offers a wide range of products and services, including Extraction Plants and Extruders, Extraction Machinery, Pharma Ingredients & Raw Materials, Anti Infective API, Industrial Construction Service, Plant Construction Service, Turnkey Consultants & Solutions, Industrial project consultants, Solvent Extraction Plant, Printing & Binding Services.
Who are the key members and board of directors at Indoco Remedies?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundeep Bambolkar  | Managing Director | 27-Mar-2004 | Current |
| Aditi Panandikar | Managing Director | 27-Mar-2004 | Current |
| Pramod Ghorpade | CFO | 02-Nov-2021 | Current |
| Hariharan Ramanathan | Company Secretary | 01-Dec-2022 | Current |
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhijit Gore | Director | 03-Oct-2020 | Current |
| Suresh Kare | Director | 02-Jul-1963 | Current |
| Satish Shenoy | Director | 12-Apr-2024 | Current |
| Vasudha Kamat | Director | 27-Mar-2020 | Current |
| Ajay Mulgaokar | Director | 12-Apr-2024 | Current |
| Anand Nadkarni | Director | 28-May-2014 | Current |
Financial Performance of Indoco Remedies.
Indoco Remedies Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.23% increase. The company also saw a slight decrease in profitability, with a 8.52% decrease in profit. The company's net worth Soared by an impressive increase of 13.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indoco Remedies?
In 2022, Indoco Remedies had a promoter holding of 58.69% and a public holding of 41.32%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Veena Patil Hospitality Private LimitedAbhijit Gore is a mutual person
Jmp Advisors Private LimitedAbhijit Gore is a mutual person
Xtend Industrial Designers And Engineers Private LimitedSundeep Bambolkar and Aditi Panandikar are mutual person
Indoco Capital Markets LimitedSuresh Kare is a mutual person
Spa Holdings Private LimitedSundeep Bambolkar and Suresh Kare are mutual person
- Warren Remedies Private Limited
Sundeep Bambolkar and Aditi Panandikar are mutual person
Charges (Loans)
₹440.06 Cr
₹667.82 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 215.00 Cr
- Others : 170.00 Cr
- Idbi Bank Limited : 14.00 Cr
- State Bank Of India : 13.65 Cr
- Standard Chartered Bank : 10.00 Cr
- Others : 17.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2024 | Hdfc Bank Limited | ₹42.00 Cr | Open |
| 30 May 2024 | Hdfc Bank Limited | ₹28.00 Cr | Open |
| 14 Dec 2023 | Hdfc Bank Limited | ₹50.00 Cr | Open |
| 16 Aug 2023 | Hdfc Bank Limited | ₹30.00 Cr | Open |
| 06 Jan 2023 | Others | ₹30.00 Cr | Open |
How Many Employees Work at Indoco Remedies?
Indoco Remedies has a workforce of 6460 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indoco Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indoco Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
